Abstract:Influenza virus diagnosis has traditionally relied on virus isolation in chicken embryo or cell cultures. Many laboratories have adopted rapid molecular methods for detection of influenza viruses and discontinued routine utilization of the relatively slow viral culture methods. We describe an influenza A virus reporter cell line that contributes to more efficient viral detection in cell culture. Madin-Darby canine kidney (MDCK) cells were engineered to constitutively produce an influenza virus genome-like luciferase reporter RNA driven by the canine RNA polymerase I promoter. Induction of a high level of luciferase activity was detected in the Luc9.1 cells upon infection with various strains of influenza A virus, including 2009 H1N1 pandemic and highly pathogenic H5N1 virus. In contrast, infection with influenza B virus or human adenovirus type 5 did not induce significant levels of reporter expression. The reporter Luc9.1 cells were evaluated in neutralizing antibody assays with convalescent H3N2 ferret serum, yielding a neutralization titer comparable to that obtained by the conventional microneutralization assay, suggesting that the use of the reporter cell line might simplify neutralization assays by facilitating the establishment of infectious virus endpoints. Luc9.1 cells were also used to determine the susceptibility of influenza A viruses to a model antiviral drug. The equivalence to conventional antiviral assay results indicated that the Luc9.1 cells could provide an alternative cell-based platform for high-throughput drug discovery screens. In summary, the MDCK-derived Luc9.1 reporter cell line is highly permissive for influenza A virus replication and provides a very specific and sensitive approach for simultaneous detection and isolation of influenza A viruses as well as functional evaluation of antibodies and antiviral molecules.

Highly-sensitive reporter cell line for detection of interferon types I-III and their neutralization by antibodies

Highly sensitive reporter cell line for detection of interferon types I–III and their neutralization by antibodies

Luciferase Reporter Systems in Investigating Interferon Antiviral Innate Immunity

A sensitive assay for measuring whole-blood responses to type I IFNs

Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies

Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and Autoimmunity

High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway

Measuring HIV neutralization in a luciferase reporter gene assay

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

Preparation,Characterization and Application of Monoclonal Antibodies to Recombinant Human Interferon—α2a

A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity

IFN-λ1 in CHO cells: its expression and biological activity

Luciferase Reporter Assay for Determining the Signaling Activity of Interferons

An extracellular humanized IFNAR immunocompetent mouse model for analyses of human interferon alpha and subtypes

Regulation and Dynamics of IFN-β Expression Revealed with a Knockin Reporter Mouse

An Interferon-Beta Promoter Reporter Assay for High Throughput Identification of Compounds Against Multiple RNA Viruses

Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays

Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means

Early interferon lambda production is induced by double-stranded RNA in iPS-derived hepatocyte-like cells

Rapid Assessment of Neutralizing Antibodies Using Influenza Viruses with a Luciferase Reporter

Engineered chimeric receptors for dissecting interferon signaling